Understanding the interactions between HSPG-related genes, including the SDCs and GPCs, Aβ accumulation, Tau pathology and other features of neural lineage specification may facilitate the development of a molecular profile of AD and TBI to identify key signalling events of early diagnosis along with more targeted therapies. Here, SDC2 is linked to Alzheimer disease.